Clinical Trial

Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.

Name: Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. — clinical trial record (NCT07044921)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated July 1, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Summary

Phase II clinical study of irinotecan liposome (II)-based combination regimen as a treatment for irinotecan-resistant colorectal cancer.

Trial Details

NCT Number	NCT07044921
Lead Sponsor	Chinese PLA General Hospital
Conditions	Colorectal Cancer Metastatic
Enrollment	30 participants
Start Date	2024-09-01
Primary Completion	2026-07-31 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-01